Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Terminated 4Recruiting 4Completed 4Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 468Neoplasms 332Colorectal Neoplasms 235Carcinoma, Non-Small-Cell Lung 235Lung Neoplasms 200Prostatic Neoplasms 182Carcinoma, Hepatocellular 175Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 115Uterine Cervical Neoplasms 111Rectal Neoplasms 103Multiple Myeloma 94Recurrence 89Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 80Ovarian Neoplasms 78Neoplasm Metastasis 77Brain Neoplasms 71Colonic Neoplasms 68Glioblastoma 67Esophageal Neoplasms 66Triple Negative Breast Neoplasms 64Endometrial Neoplasms 61Small Cell Lung Carcinoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Motor Activity 54Hematologic Neoplasms 54Disease 54Glioma 48

Interventions

pembrolizumab 1Pemetrexed 1Injections 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Non-small Cell Lung Cancer Metastatic × Clear all
NCT06045767 2024-06-03

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer

Tel Aviv Medical Center

Phase 2 Not yet recruiting
30 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡